Diabetes Drugs by Design

November 30, 2022

In part 3 of the MedEvidence Diabetes series Dr. Koren and Sharon Smith discuss choosing drug classes for diabetes, weight loss and cardiovascular health.

💉GLP-1 Drug Class
💉SGLT2i Drug Class
🔬 Past and New Clinical Research Trials

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Sharon Smith, RN, CDCES, is the VP of Recruitment at ENCORE Research Group and a Diabetic Educational Nurse with a passion for educating patients as well as staff on healthy lifestyle options without giving up on special treats.

Prefer to listen to the podcast without video? You can do that below!

Encore logo

As a proven clinical research organization, we take every precaution to ensure the safety of and maximize the value for our research volunteers. Qualified doctors, nurses and study coordinators on staff provide support and care throughout the research trial. Participation is always voluntary. We appreciate the time and effort that research volunteers bring to this important process.

Copyright 2023 ENCORE Research Group